About
Brandon Capital Partners is a venture Capital firm focused on investing in life science companies, from early stage seed investments through to growth Capital. The firm is dedicated to developing the next generation of medical innovations, supporting companies through proofofconcept to commercialisation. With a strong presence across Australia, New Zealand, the United States, and the United Kingdom, Brandon Capital Partners has been effective in raising successive funds, providing significant capacity to support its advancing portfolio companies. Their investment portfolio includes a variety of companies developing cutting edge technologies aimed at improving patient outcomes. Notable portfolio companies include Perx, Pheon Therapeutics, TamoRx, NRG Therapeutics, Entact Bio, CatalYm, Myricx Bio, and Axelia Oncology.